GoHearing Ultra vs Signia Pure C&G IX

The GoHearing Ultra is a budget-priced OTC behind-the-ear hearing aid that earned a B grade with a SoundScore of 3.1/5 in our lab testing. At $499, it sits in the most affordable tier of OTC devices, though its overall performance ranks 58th out of 65 OTC hearing aids tested. This device shows a distinctive performance profile with notable strengths in specific areas. Feedback handling earned an excellent 5.0/5, scoring 0.46 points above the category average—meaning users are unlikely to experience whistling or squealing during typical use. Music streaming also performed well at 3.6/5, a solid score that sits 1.68 points above the OTC average of 1.92/5, making it a reasonable choice for those who prioritize phone audio streaming. However, the GoHearing Ultra struggles in core speech understanding metrics. Speech in quiet scored just 1.0/5, falling 1.79 points below the category average, while speech in noise also scored 1.0/5, sitting 0.48 points below average. Own-voice comfort measured 1.9/5, which is 0.61 points below the typical OTC device. These low speech scores significantly limit the device's utility for its primary purpose of improving conversation clarity. Consumers seeking better overall value in this price range may want to consider alternatives like the Elehear Beyond (4.36/5) or Apple AirPods Pro 2 (4.06/5), which deliver substantially stronger speech performance. The GoHearing Ultra may suit buyers who prioritize streaming audio and feedback-free wear over speech enhancement, but those seeking meaningful speech benefit should explore higher-performing options.

The Signia Pure C&G IX is a premium prescription behind-the-ear hearing aid released in 2023, currently available at $3,298. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.1/5, ranking #20 among 36 prescription hearing aids tested. This device demonstrates consistent strength across multiple performance areas. Speech in quiet scored a solid 4.0/5, sitting 0.65 points above the category average. Speech in noise performance, while above the category average by 0.25 points, remains mixed in absolute terms at 2.2/5—a common challenge across prescription devices. Feedback handling is a standout feature, achieving a perfect 5.0/5 and exceeding the already-high category average. Own-voice comfort scores a solid 3.2/5, running 0.45 points above the category average, which suggests good occlusion management. Music streaming performs solidly at 3.0/5, also above average for the category by 0.36 points. The device supports both iPhone and Android streaming along with hands-free functionality. Professional tuning yields meaningful improvement, with the normalized score increasing from 4.0/5 to 4.5/5. Buyers seeking top-tier performance in this price range should note that competitors like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5) scored higher in our testing. The Pure C&G IX may suit those who prioritize reliable feedback control and balanced everyday performance over maximum speech-in-noise capability.